H3K27ac as Metabolic-Epigenetic Link: MCT1-Pyruvate Axis Regulates B Cell Class Switch Recombination

Core Definition of H3K27ac as Active Chromatin Biomarker

Histone H3 lysine 27 acetylation (H3K27ac) acts as a canonical epigenetic marker marking open, transcriptionally permissive chromatin domains across mammalian immune cell populations. This reversible post-translational modification neutralizes positively charged lysine side chains to loosen histone-DNA electrostatic binding, enabling transcription factor and RNA polymerase recruitment at promoters and super-enhancer loci. Intracellular acetyl-CoA pools derived from glycolytic metabolites serve as the primary acetyl group donors for H3K27ac deposition, directly linking cellular nutrient metabolism to transcriptional programming in activated lymphocytes. Dynamic shifts in H3K27ac abundance coordinate B cell differentiation, antibody diversification and inflammatory transcriptional circuits under antigen stimulation culture conditions.

Research Background: Unresolved MCT1 Function in Activated B Cells

Monocarboxylate transporter 1 (MCT1) mediates bidirectional transmembrane transport of pyruvate and lactate intermediates during immune cell metabolic reprogramming. Prior transcriptomic profiling consistently recorded elevated MCT1 expression in antigen-stimulated B cell populations, yet its downstream functional impacts on antibody production remained uncharacterized before the joint work from Tsinghua University’s Chen Ligong and Liu Wanli research groups. Mature B cells undergo dramatic glycolysis upregulation upon activation to supply biomass and epigenetic cofactors for class switch recombination (CSR). No established molecular pathway had connected monocarboxylate flux to histone modification landscapes controlling Aicda (AID) gene transcription, creating a critical knowledge gap bridging immunometabolism and chromatin regulation basic research.

Core Experimental Design & Research Methodology

The research team generated B cell-specific MCT1 conditional knockout (Mb1-Cre Mct1f/f) murine models to eliminate transporter expression exclusively within lymphocyte lineages. In vivo immunization assays utilized NP-KLH antigen to quantify antigen-specific IgM and IgG antibody secretion alongside germinal center B cell frequency metrics. Ex vivo primary B cell cultures with LPS plus IL-4 stimulation recapitulated CSR phenotypes for mechanistic dissection. Isotope-labeled U-¹³C glucose metabolic tracing tracked glycolytic and TCA cycle flux shifts upon MCT1 ablation. Multi-omics pipelines including RNA-seq, ATAC-seq and ChIP-seq mapped transcriptome, chromatin accessibility and genome-wide H3K27ac deposition patterns in wild-type versus knockout B cell isolates. Selective MCT inhibitor CHC and cell-permeable methyl pyruvate supplementation were applied to validate pyruvate as the functional intermediate metabolite driving epigenetic remodeling events.

Key Research Findings Stepwise Breakdown

1. MCT1 deletion does not disrupt early B cell developmental trajectories or basal circulating IgM concentrations, yet induces profound CSR defects post antigen challenge. Knockout mice display drastically reduced NP-specific IgG titers, lowered germinal center B cell proportions and impaired ex vivo IgG1 conversion efficiency after cytokine stimulation cycles.

2. MCT1 ablation rewires central carbon metabolism to suppress glycolytic flux while amplifying oxidative phosphorylation activity, triggering intracellular pyruvate depletion without lactate accumulation. TCA cycle intermediates citrate, succinate and malate accumulate within knockout B cell cytoplasmic compartments.

3. Reduced intracellular pyruvate availability downregulates AID enzyme transcription via suppressed H3K27ac enrichment at the Aicda promoter and enhancer regions. Chromatin accessibility measured via ATAC-seq declines sharply at Aicda loci in MCT1-deficient lymphocytes.

4. Altered balance between histone acetyltransferase CBP and deacetylases HDAC2/SIRT1 accounts for global H3K27ac loss; SIRT1 inhibitor treatment partially restores AID expression and IgG1 CSR capacity in knockout cell cultures. Carbon tracing data verifies pyruvate-derived acetyl units directly incorporate into H3K27 modification sites.

5. MCT1 transcript levels are significantly elevated in peripheral immune cells from systemic lupus erythematosus (SLE) model subjects. MCT1 knockout alleviates splenomegaly, germinal center expansion and pathogenic anti-dsDNA IgG deposition in murine lupus preclinical assay systems. MCT inhibitor CHC recapitulates this protective phenotype to validate the transporter as a modifiable immunometabolic research target.

MCT1-Pyruvate-H3K27ac-AID Regulatory Axis Mechanism Summary

Activated B cells upregulate MCT1 to maintain sufficient cytoplasmic pyruvate concentrations originating from glycolytic breakdown. Pyruvate feeds acetyl-CoA biosynthesis pathways to sustain genome-wide H3K27ac deposition, particularly at the Aicda super-enhancer domain. Robust H3K27ac labeling maintains open chromatin architecture to support high-level AID transcription, which catalyzes DNA strand breaks required for immunoglobulin heavy chain class switch recombination. Loss of MCT1 limits pyruvate import and acetyl-CoA production, shifting HAT/HDAC equilibrium toward deacetylated chromatin states that silence AID expression and block IgG antibody generation. This unified metabolic-epigenetic cascade establishes a tractable experimental model for studying nutrient-dependent immune differentiation programs.

Experimental Reagent Requirements for H3K27ac Immunometabolism Research

Systematic dissection of this signaling axis relies on two core detection reagents from ANT BIO PTE. LTD. to quantify acetylated histone landscapes and global lysine acetylation proteomes. Site-specific H3K27ac recombinant rabbit monoclonal antibody enables ChIP-seq, ChIP-qPCR, WB and tissue IHC profiling to map locus-specific histone modification gradients. Pan anti-acetyllysine agarose beads support proteomic enrichment of all acetylated cellular proteins for untargeted acetylome mass spectrometry screening workflows. Combined use of these two reagents enables parallel chromatin and proteome-level acetylation quantification across MCT1 knockout and wild-type B cell comparative cohorts.

Fundamental Research Applications of ANT BIO PTE. LTD. H3K27ac & Acetyl-Lysine Reagents

FFPE splenic tissue IHC quantifies H3K27ac spatial gradients within germinal center B cell populations from immunized murine specimens. ChIP-seq utilizing S0B0546 antibody maps genome-wide H3K27ac enhancer peaks to identify CSR-associated transcriptional loci. Western blot analysis monitors global H3K27ac abundance shifts following MCT inhibitor or methyl pyruvate supplementation cycles. Anti-acetyllysine agarose bead immunoprecipitation enriches acetylated peptide pools for LC-MS/MS acetylome profiling in activated primary B cell lysates. Multi-color immunofluorescence co-staining pairs H3K27ac markers with B220 germinal center biomarkers to visualize epigenetic heterogeneity across splenic immune microdomains.

ANT BIO PTE. LTD. Acetylation Detection Reagent Portfolio

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs
At ANT BIO PTE. LTD., we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.

Disclaimer
This article was partially created with the assistance of artificial intelligence. If any content involves copyright or intellectual property issues, please inform us, and we promise to verify and remove it immediately.